Commentary on recent Alzheimer’s trial failures: comparative functional genomic meta-analysis of Alzheimer’s affected and naturally aging brains
博士 === 國立中央大學 === 系統生物與生物資訊研究所 === 107 === Alzheimer's disease (AD) is a prevalent progressive neurodegenerative human disease. Several initially highly hopeful anti-AD drugs based on the amyloid-β (Aβ) hypothesis of AD have failed recent late-phase tests, and the cause of AD remains unclear....
Main Authors: | Yi-Shian Peng, 彭奕憲 |
---|---|
Other Authors: | Hoong-Chien Lee |
Format: | Others |
Language: | en_US |
Published: |
2019
|
Online Access: | http://ndltd.ncl.edu.tw/handle/wr6r44 |
Similar Items
-
Comparative functional genomic analysis of Alzheimer’s affected and naturally aging brains
by: Yi-Shian Peng, et al.
Published: (2020-03-01) -
Composite neurocognitive endpoints in Alzheimer's disease clinical trials: A commentary
by: Christopher Randolph
Published: (2020-01-01) -
Commentary on Composite cognitive and functional measures for early stage Alzheimer's disease trials
by: Dorene M. Rentz, et al.
Published: (2020-01-01) -
Commentary: Composite cognitive and functional measures for early stage Alzheimer's disease trials
by: John E. Harrison
Published: (2020-01-01) -
Iridoids and Other Monoterpenes in the Alzheimer’s Brain: Recent Development and Future Prospects
by: Solomon Habtemariam
Published: (2018-01-01)